Biochemical characterization of plasmepsin V from Plasmodium vivax Thailand isolates: Substrate specificity and

Khomkrit Sappakhaw1, Ratchaneekorn Takasila1, Pichamon Sittikul1

  • 1Department of Biochemistry, Special Research Unit for Protein Engineering and Protein Bioinformatics, Faculty of Science, Kasetsart University, 50 Ngam Wong Wan Road, Lat Yao, Chatuchak, Bangkok 10900, Thailand.

Insights

Plasmepsin V (PMV) is crucial for malaria parasite survival. This study characterizes Plasmodium vivax PMV (PvPMV) from Thailand, revealing its structure, activity, and inhibition, offering insights for drug development.

Area of Science:

  • Molecular Parasitology
  • Enzymology
  • Structural Biology

Background:

  • Plasmepsin V (PMV) is essential for Plasmodium parasite viability, mediating the cleavage of the Plasmodium export element (PEXEL) motif.
  • Understanding Plasmodium vivax PMV (PvPMV) is critical for developing antimalarial strategies.

Purpose of the Study:

  • To genetically characterize Plasmodium vivax PMV (PvPMV) from Thailand isolates.
  • To clone, express, purify, and characterize the recombinant PvPMV-Thai enzyme.
  • To investigate the substrate specificity and inhibition of PvPMV-Thai.

Main Methods:

  • Genetic analysis of PvPMV isolates from Thailand.
  • Recombinant protein expression, refolding, and purification of PvPMV-Thai.
  • Enzyme activity assays with various peptide substrates and inhibitors.

Main Results:

  • PvPMV-Thai possesses a unique four-amino acid insertion (SVSE) at residues 246-249, which does not affect catalytic activity.
  • PvPMV-Thai efficiently hydrolyzes PfEMP2 over HRPII, similar to PfPMV.
  • Substrate specificity studies revealed subtle differences in the S2 binding pocket between PvPMV and PfPMV.
  • Menisporopsin A was identified as a partial inhibitor of PvPMV-Thai at high concentrations.

Conclusions:

  • Recombinant production of PvPMV-Thai is feasible using the described methods.
  • PvPMV-Thai exhibits distinct substrate specificity compared to PfPMV, particularly at the P2 position.
  • Menisporopsin A shows potential as an inhibitor, warranting further investigation for antimalarial drug development.